Friday, April 18, 2014 9:48:45 PM
Disease Outbreak
4/15/2014
The U.S. Embassy in Santo Domingo, Dominican Republic, informs U.S. citizens of a public health concern regarding the chikungunya virus. Chikungunya virus is a mosquito transmitted virus recently identified in Dominican Republic after spreading there from other Caribbean islands. Symptoms typically include fever and severe joint pain of the hands and feet that begin 3-7 days after being bitten by an infected mosquito. Other symptoms may include muscle pain, headache, fever, joint swelling, and rash. There is no vaccine or medication to prevent chikungunya virus infection or any antiviral medications to treat it at this time. While deaths are rare, people at increased risk for severe disease include newborns, adults over 65 years, and those with chronic health conditions.
The presentation of chikungunya is similar to dengue. Citizens are encouraged to seek medical attention if they are showing symptoms, and especially if the fever is over 102 F (above 39 C). Anyone sick with chikungunya should avoid mosquito bites to help prevent further spreading of the virus. The Centers for Disease Control have some excellent websites for additional information on the chikungunya virus.
Chikungunya, dengue and malaria are all mosquito borne illnesses that are present in the Dominican Republic. At this time, prevention of these infections is focused on reducing mosquito exposure by using repellents, covering exposed skin, treating clothing and tents with permethrin and sleeping in screened or air conditioned rooms. Important mosquito control measures include emptying water from outdoor containers and using sprays. Travelers should carry and use CDC recommended insect repellents containing either 20% DEET, picaridin, oil of lemon eucalyptus or IR3535 will help diminish bites from mosquitoes as well ticks, fleas, chiggers, etc, some of which may also carry infectious diseases.
http://www.cdc.gov/chikungunya/fact/index.html
http://www.cdc.gov/chikungunya/
http://www.cdc.gov/chikungunya/pdfs/CHIKV_FACT%20SHEET_CDC_General%20Public_cleared_spanish.pdf
To obtain Centers for Disease Control and Prevention (CDC) travel notices, call the CDC at 1-800-CDC-INFO (1-800-232-4636) from within the United States, or 1-404-639-3534 from overseas, or visit the CDC website at http://www.cdc.gov/travel.
We strongly recommend that U.S. citizens traveling to or residing in Dominican Republic enroll in the Department of State’s Smart Traveler Enrollment Program (STEP) at www.Travel.State.Gov. STEP enrollment gives you the latest security updates, and makes it easier for the U.S. embassy or nearest U.S. consulate to contact you in an emergency. If you don’t have Internet access, enroll directly with the nearest U.S. embassy or consulate.
Regularly monitor the State Department's website, where you can find current Travel Warnings, Travel Alerts, and the Worldwide Caution. Read the Country Specific Information for the Dominican Republic. For additional information, refer to "A Safe Trip Abroad" on the State Department's website.
Emergencies involving U.S. citizens can be reported by contacting the American Citizen Services (ACS) Unit of the U.S. Embassy’s Consular Section, located at Calle Nicolas Penson and Maximo Gomez, telephone (809) 221-2171, and e-mail at SDOAmericans@state.gov. The U.S. Consular Agency in Puerto Plata can be reached at (809) 589-8017. The U.S. Consular Agency in Punta Cana/Bavaro can be reached at (809) 552-8990.
https://www.osac.gov/Pages/ContentReportDetails.aspx?cid=15510&__Referrer=afternoon_digest_16_04_2014
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM